MX2019006326A - Derivados de tirosina y composiciones que los comprenden. - Google Patents
Derivados de tirosina y composiciones que los comprenden.Info
- Publication number
- MX2019006326A MX2019006326A MX2019006326A MX2019006326A MX2019006326A MX 2019006326 A MX2019006326 A MX 2019006326A MX 2019006326 A MX2019006326 A MX 2019006326A MX 2019006326 A MX2019006326 A MX 2019006326A MX 2019006326 A MX2019006326 A MX 2019006326A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- tyrosine hydroxylase
- hydroxylase inhibitor
- tyrosine derivatives
- subject
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000003667 tyrosine derivatives Chemical class 0.000 title 1
- 229940122110 Tyrosine hydroxylase inhibitor Drugs 0.000 abstract 4
- 239000002246 antineoplastic agent Substances 0.000 abstract 2
- 230000004663 cell proliferation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Son proporcionadas composiciones y equipos que comprenden un inhibidor de la tirosina hidroxilasa y un agente anticáncer que está unido químicamente a, o asociado físicamente con el inhibidor de la tirosina hidroxilasa. También se proporcionan métodos para reducir la proliferación celular en un sujeto que comprende administrar un sujeto que necesite de los mismo una composición que comprende un inhibidor de la tirosina hidroxilasa y un agente anticáncer que es unido químicamente a, o asociado físicamente con, el inhibidor de la tirosina hidroxilasa.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/365,120 US20170080093A1 (en) | 2013-10-22 | 2016-11-30 | Tyrosine Derivatives And Compositions Comprising Them |
| PCT/US2017/063865 WO2018102506A1 (en) | 2016-11-30 | 2017-11-30 | Tyrosine derivatives and compositions comprising them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019006326A true MX2019006326A (es) | 2019-07-12 |
Family
ID=60703174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019006326A MX2019006326A (es) | 2016-11-30 | 2017-11-30 | Derivados de tirosina y composiciones que los comprenden. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3548086A1 (es) |
| JP (2) | JP2019536783A (es) |
| KR (1) | KR20190089191A (es) |
| CN (1) | CN110062633A (es) |
| AU (1) | AU2017368135A1 (es) |
| BR (1) | BR112019011033A2 (es) |
| CA (1) | CA3045110A1 (es) |
| EA (1) | EA201991305A1 (es) |
| IL (1) | IL266840A (es) |
| MX (1) | MX2019006326A (es) |
| PH (1) | PH12019501186A1 (es) |
| WO (1) | WO2018102506A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111743887A (zh) * | 2019-03-26 | 2020-10-09 | 深圳先进技术研究院 | α-甲基酪氨酸或其衍生物的用途 |
| CA3140042A1 (en) | 2019-05-14 | 2020-11-19 | Tyme, Inc. | Compositions and methods for treating cancer |
| CA3167918A1 (en) * | 2020-01-17 | 2021-07-22 | Tyme, Inc. | Compositions and methods for modulating cancer |
| US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI323662B (en) * | 2002-11-15 | 2010-04-21 | Telik Inc | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| WO2005072061A2 (en) * | 2004-02-02 | 2005-08-11 | Biosight Ltd. | Conjugates for cancer therapy and diagnosis |
| KR101653182B1 (ko) * | 2006-04-19 | 2016-09-01 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 세포 영상화 및 치료를 위한 조성물 및 방법 |
| HUE027443T2 (en) * | 2007-09-10 | 2016-10-28 | Boston Biomedical Inc | A novel class of Stat3 pathway inhibitors and tumor stem cell inhibitors |
| CN104220057B (zh) * | 2012-01-17 | 2017-11-03 | 迪美公司 | 药物组合物和方法 |
| US9585841B2 (en) | 2013-10-22 | 2017-03-07 | Tyme, Inc. | Tyrosine derivatives and compositions comprising them |
-
2017
- 2017-11-30 AU AU2017368135A patent/AU2017368135A1/en not_active Abandoned
- 2017-11-30 CA CA3045110A patent/CA3045110A1/en active Pending
- 2017-11-30 CN CN201780074235.7A patent/CN110062633A/zh active Pending
- 2017-11-30 KR KR1020197018473A patent/KR20190089191A/ko not_active IP Right Cessation
- 2017-11-30 BR BR112019011033A patent/BR112019011033A2/pt unknown
- 2017-11-30 WO PCT/US2017/063865 patent/WO2018102506A1/en unknown
- 2017-11-30 EP EP17817552.7A patent/EP3548086A1/en active Pending
- 2017-11-30 EA EA201991305A patent/EA201991305A1/ru unknown
- 2017-11-30 MX MX2019006326A patent/MX2019006326A/es unknown
- 2017-11-30 JP JP2019528632A patent/JP2019536783A/ja active Pending
-
2019
- 2019-05-23 IL IL266840A patent/IL266840A/en unknown
- 2019-05-29 PH PH12019501186A patent/PH12019501186A1/en unknown
-
2022
- 2022-08-01 JP JP2022122538A patent/JP2022153587A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP3548086A1 (en) | 2019-10-09 |
| CA3045110A1 (en) | 2018-06-07 |
| JP2019536783A (ja) | 2019-12-19 |
| AU2017368135A1 (en) | 2019-06-13 |
| WO2018102506A1 (en) | 2018-06-07 |
| PH12019501186A1 (en) | 2020-02-10 |
| BR112019011033A2 (pt) | 2019-10-15 |
| JP2022153587A (ja) | 2022-10-12 |
| EA201991305A1 (ru) | 2019-10-31 |
| KR20190089191A (ko) | 2019-07-30 |
| CN110062633A (zh) | 2019-07-26 |
| IL266840A (en) | 2019-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20190478A (es) | Inhibidores de pd-1/pd-l1 | |
| PH12019501186A1 (en) | Tyrosine derivatives and composition comprising them | |
| CR20210013A (es) | Inhibidores de pd-1/pd-l1 | |
| MY195110A (en) | Antibodies to PD-1 and uses Thereof | |
| PH12018500647A1 (en) | Affinity-oligonucleotide conjugates and uses thereof | |
| MX2017013613A (es) | Neoepitodos de cancer. | |
| MY199019A (en) | Pd-1 antibodies | |
| CL2016001231A1 (es) | Compuestos de inhibidor de autotaxina | |
| MX2019007276A (es) | Composiciones y métodos para mejora o aumento de la producción de ifn tipo i. | |
| WO2015002724A3 (en) | SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME | |
| TWD173671S (zh) | 通訊耳機之部分 | |
| AU2018341571A8 (en) | Therapeutic methods relating to HSP90 inhibitors | |
| WO2019006005A3 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA | |
| CR20110553A (es) | Terapia complementaria contra el cáncer | |
| MX2015013177A (es) | Combinacion de tratamientod de cancer usando microarns e inhibidores de egfr-tki. | |
| MX2017008414A (es) | Composiciones inhibidoras de nitrificacion y metodos para preparar las mismas. | |
| WO2017132746A8 (en) | Ubiquitin variants and uses thereof as 53bp1 inhibitors | |
| MX2015009818A (es) | Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerosis multiple. | |
| MX2021008839A (es) | Composiciones aglomerantes y metodos para fabricacion y uso de las mismas. | |
| WO2018009507A8 (en) | COMBINATION OF A TIM -4 ANTAGONIST AND METHODS OF USE | |
| MX2016015568A (es) | Derivados de nucleosidos para el tratamiento del cancer. | |
| WO2018208954A3 (en) | Peptidomimetic macrocycles and uses thereof | |
| WO2015181624A3 (en) | Nucleoside derivatives for the treatment of cancer | |
| WO2019043176A3 (en) | HISTONE-DEACETYLASE INHIBITOR IN COMBINATION WITH ANTIMETABOLITE AGENT FOR CANCER THERAPY | |
| EA202191631A1 (ru) | Композиции, содержащие бактериальные штаммы |